The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. It's now a manageable infection. A person with HIV who takes HIV medicine consistently, before their ...

Multiple key Oregon football starters could declare for the 2026 NFL Draft following their elimination from the College Football Playoff in the... Back in 1983, getting diagnosed with HIV meant ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when ...

Advocates warn the cuts to Florida’s AIDS Drug Assistance Program may increase health risks statewide and reduce access for thousands.

Johnson syndrome, a rare and life-threatening drug reaction, after taking HIV post-exposure medicines based on AI advice.

Researchers found that lithium can suppress HIV reactivation in lab-grown human cells through an unexpected, ...

The federal government announced the next 15 medicines for which it will seek price reductions with the help of Medicare’s new negotiating power, including the breast cancer drugs Kisqali and Verzenio ...